Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dermatology
Pharma
Veradermics’ oral hair loss drug passes 1-year ph. 3 test
Veradermics' oral minoxidil scored what Citi analysts called "better-than-expected" one-year data in male pattern hair loss.
Donavyn Coffey
Nov 9, 2026 2:52pm
Galderma targets medical skincare growth with $1.5B Zo buyout
Oct 14, 2026 10:31am
Novartis expands Rhapsido's growing reach in chronic hives
Oct 7, 2026 2:27pm
Litfulo and tilrekimig data bolster Pfizer's immunology plans
Oct 2, 2026 11:15am
Organon phones home with sci-fi themed Vtama campaign
Sep 30, 2026 4:36pm
Veradermics reports ph. 2 win in female pattern hair loss
Jul 15, 2026 11:27am